These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11078200)

  • 1. N-[1-(2-Phenylethyl)pyrrolidin-3-yl]-1-adamantanecarboxamides as novel 5-HT2 receptor antagonists.
    Fujio M; Kuroita T; Sakai Y; Nakagawa H; Matsumoto Y
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2457-61. PubMed ID: 11078200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
    Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2-(omega-phenylalkyl)phenoxy]alkylamines.II: Synthesis and selective serotonin-2 receptor binding.
    Tanaka N; Goto R; Ito R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):245-55. PubMed ID: 10705513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist properties.
    Sills MA; Bennett DA; Lovell RA; Liebman JM; Wood PL; Glaeser BS; Williams M; Hutchison AJ
    Prog Clin Biol Res; 1990; 361():469-75. PubMed ID: 1981265
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and serotonin 2 (5-HT2) receptor antagonist activity of 5-aminoalkyl-substituted pyrrolo[3,2-c]azepines and related compounds.
    Mizuno A; Ogata A; Kamei T; Shibata M; Shimamoto T; Hayashi Y; Nakanishi K; Takiguchi C; Oka N; Inomata N
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):623-35. PubMed ID: 10823697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.
    Takao K; Nagatani T; Kitamura Y; Yamawaki S
    Eur J Pharmacol; 1997 Aug; 333(2-3):123-8. PubMed ID: 9314024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-[[1-(2-phenylethyl)pyrrolidin-2-yl]methyl]cyclohexanecarboxamides as selective 5-HT1A receptor agonists.
    Fujio M; Togo Y; Tomozane H; Kuroita T; Morio Y; Katayama J; Matsumoto Y
    Bioorg Med Chem Lett; 2000 Mar; 10(5):509-12. PubMed ID: 10743959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.
    Johansson L; Sohn D; Thorberg SO; Jackson DM; Kelder D; Larsson LG; Rényi L; Ross SB; Wallsten C; Eriksson H; Hu PS; Jerning E; Mohell N; Westlind-Danielsson A
    J Pharmacol Exp Ther; 1997 Oct; 283(1):216-25. PubMed ID: 9336327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
    Scandroglio A; Monferini E; Borsini F
    Pharmacol Res; 2001 Feb; 43(2):179-83. PubMed ID: 11243720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors.
    Maura G; Roccatagliata E; Ulivi M; Raiteri M
    Eur J Pharmacol; 1988 Jan; 145(1):31-8. PubMed ID: 2965025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2-(O-Phenylalkyl)phenoxy]alkylamines III: Synthesis and selective serotonin-2 receptor binding (2).
    Tanaka N; Goto R; Ito R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1729-39. PubMed ID: 11086903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
    Herndon JL; Ismaiel A; Ingher SP; Teitler M; Glennon RA
    J Med Chem; 1992 Dec; 35(26):4903-10. PubMed ID: 1479590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ; Goodwin GM; Green AR; Heal DJ
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635.
    Mensonides-Harsema MM; Liao Y; Böttcher H; Bartoszyk GD; Greiner HE; Harting J; de Boer P; Wikström HV
    J Med Chem; 2000 Feb; 43(3):432-9. PubMed ID: 10669570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.